CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes

被引:47
|
作者
Liu, Che [1 ]
Luo, Defang [1 ]
Streit, Wolfgang J. [2 ]
Harrison, Jeffrey K. [1 ]
机构
[1] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA
关键词
chemokine; GL261; glioblastoma multiforme; tumor immunology;
D O I
10.1016/j.jneuroim.2008.04.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human glioblastoma multiforme (GBM) is the most malignant form of human brain tumors. A characteristic of GBM is the marked presence of tumor infiltrated microglia/macrophages and lymphocytes. The goal of this study was directed toward understanding the role of the chemokine system CX3CL1 and its receptor CX3CR1 in the GL261 murine model of malignant glioma. In situ hybridization analysis identified CX3CL1 and CX3CR1 expression in GL261 tumors. The impact of CX3CR1 deletion on the growth of intracranial GL261 gliomas and associated immune cell infiltration was evaluated in CX3CR1 gene-disrupted C57BL/6 mice. A slight increase in the tumor growth rate in CX3CR1-/- mice was evident with similar numbers of microglia and CD4(+), CD8(+), FoxP3(+), or Ly49G2(+) lymphocytes within tumors established in CX3CR1 +/- and -/- mice. These data indicate that CX3CR1 has little or no effects on either gliomagenesis or the migration of microglia and lymphocytes into GL261 tumors. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:98 / 105
页数:8
相关论文
共 50 条
  • [1] Regulation of microglia neurotoxicity by CX3CR1 and CX3CL1
    Cardona, AE
    Huang, DR
    Sasse, ME
    Kidd, G
    Lira, S
    Cook, D
    Jung, S
    Littman, D
    Ransohoff, R
    FASEB JOURNAL, 2005, 19 (04): : A940 - A940
  • [2] The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
    Pawelec, Paulina
    Ziemka-Nalecz, Malgorzata
    Sypecka, Joanna
    Zalewska, Teresa
    CELLS, 2020, 9 (10) : 1 - 17
  • [3] Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
    Stavros Apostolakis
    Demetrios Spandidos
    Acta Pharmacologica Sinica, 2013, 34 : 1251 - 1256
  • [4] Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
    Apostolakis, Stavros
    Spandidos, Demetrios
    ACTA PHARMACOLOGICA SINICA, 2013, 34 (10) : 1251 - 1256
  • [5] Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
    Limatola, Cristina
    Ransohoff, Richard M.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [6] Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
    Wojdasiewicz, Piotr
    Turczyn, Pawel
    Dobies-Krzesniak, Barbara
    Frasunska, Justyna
    Tarnacka, Beata
    MEDIATORS OF INFLAMMATION, 2019, 2019
  • [7] CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases
    Subbarayan, Meena S.
    Joly-Amado, Aurelie
    Bickford, Paula C.
    Nash, Kevin R.
    PHARMACOLOGY & THERAPEUTICS, 2022, 231
  • [8] Increased expression of CX3CL1 and CX3CR1 in papillary thyroid carcinoma
    Wu, Wei
    Ren, Fu
    Guo, Miao
    Yang, Jing
    Xiao, Yanjie
    Liu, Wei
    HISTOLOGY AND HISTOPATHOLOGY, 2020, 35 (10) : 1189 - 1196
  • [9] Chemokine receptors CX3CR1 and CXCR3 and their associated ligands in the GL261 murine model of malignant glioma
    Luo, Defang
    Streit, Wolfgang
    Harrison, Jeffrey
    NEURO-ONCOLOGY, 2007, 9 (04) : 501 - 502
  • [10] CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection
    Chen, Peiqing
    Zhao, Wenjuan
    Guo, Yanjie
    Xu, Juan
    Yin, Ming
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016